Press about RVC

Artificial Intelligence Can be Used to Test School Work
24.04.2020
One of the practical results of the Up Great technology contest READ // ABLE may become the introduction in the near future of technologies for processing the natural language of a person (NLP, Natural Language Processing) in the practice of schools and universities, the organizers of the online conference dedicated to the contest said.
Human Stem Cells Institute Subsidiary, Center for Genetics and Reproductive Medicine Genetico have concluded a license agreement with the Mount Sinai hospital (Icahn School of Medicine at Mount Sinai) for the right to use a highly specific antigen for coronavirus SARS-CoV-2 to develop and commercialize a product for testing infected and those who have survived COVID-19.
The technology business sees the crisis as not only a threat, but also an opportunity for growth. About a third of companies plan expansion — for example, projects in the field of medicine and logistics. Alexander Povalko, CEO of Russian Venture Company, told Rossiyskaya Gazeta about support measures that will compensate for some problems that have arisen and will help to support the expansion of companies.
Speaking at the Online Conference “Pandemic 2020: Opportunities and Barriers for the Innovation Sector” on April 13, Director of RVC subsidiaries Mikhail Fedotov urged all participants of the venture industry not to wait for large-scale and long-term financial assistance, but to quickly adapt their forecasts and strategies to the existing negative realities.
With the resumption of the educational process in schools, the media spread information that distance learning systems could not withstand the load due to multiple increases in the number of users. RVC conducted a situation analysis to assess the extent and possible consequences of what is happening.


Search by name:

Search by date:

Select date in calendar
Select date in calendar
Venue: